openPR Logo
Press release

Middle-East and Africa Hypertension Drugs Market 2018 | Top 10 Major Participants: Abbott, Johnson & Johnson Services, Inc., Novartis, GlaxoSmithKline plc., AstraZeneca, Bayer AG

Hypertension Drugs Market

Hypertension Drugs Market

The, Hypertension Drugs Market inquire about report is developing with the quick pace; chiefly due the prospering Healthcare Sector. As per a current report distributed by the Market Research Future, The Hypertension Drugs Industry Research report is blasting and anticipated that would pick up unmistakable quality over the conjecture time frame. The Market is anticipated to exhibit a colossal development by 2022, outperforming its past development records as far as esteem and volume.

You can get easy access to samples from the report here: https://www.marketresearchfuture.com/sample_request/2636 .

Market Synopsis of Middle-East and Africa Hypertension Drugs Market:

Hypertension or high blood pressure is the condition when blood pressure increases to the unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and control high blood pressure to protect organs like brain, heart, kidneys. Hypertension affects four out of ten adults in Middle East and Africa region. Over 1.5 million deaths occurs due to hypertension in Middle East and Africa. Countries in Middle East and Africa bear a heavy burden from hypertension diagnosis and treatment. Huge funding in R&D and various initiatives by government are driving the growth for Hypertension Drugs Market in Middle East and Africa. Middle-East and Africa Hypertension Drugs Market is growing moderately. The market is growing at the CAGR of 3.1% and expected to reach to US$ 5.31 billion by 2022.

Key Players for Middle-East and Africa Hypertension Drugs Market:

Some of the key players in this market are: Abbott (US), Johnson & Johnson Services, Inc. (US), Novartis (Switzerland), GlaxoSmithKline plc.(UK), AstraZeneca (UK), Bayer AG (Germany), Pfizer Inc.(US), Merck & Co., Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Gilead (US)

What makes our report unique?

1) An extensive research study on the Global Hypertension Drugs market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Hypertension Drugs market.

2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.

3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.

Market Assessmrnt:

The report for Middle-East and Africa Hypertension Drugs Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Intended Audience

Middle-East and Africa Hypertension Drugs manufacturers
Middle-East and Africa Hypertension Drugs Suppliers
Government and Independent Regulatory Authorities
Research and Development (R&D) Companies
Independent Research Laboratories
Market Research and Consulting Service Providers
Medical Research Laboratories
Regional Analysis of Middle-East and Africa Hypertension Drugs Market:

Considering the Middle-East and Africa Hypertension Drugs Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Hypertension Drugs. Moreover Saudi Arabia market is also growing and second largest market for Hypertension Drugs. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Hypertension Drugs during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

Any query or specific requirement? Ask to our industry expert: https://www.marketresearchfuture.com/enquiry/2636 .

Segments:

Middle-East and Africa Hypertension Drugs Market has been segmented on the basis of type which comprise Thiazide diuretics, Beta blockers, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers, Calcium channel blockers, Renin inhibitors, Alpha blockers, Alpha-beta blockers, Central-acting agents, Vasodilators, Aldosterone antagonists, and others.

Table Of Content:

Chapter 1. Report Prologue

Chapter 2. Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

Chapter 3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

Chapter 5. Market Factor Analysis

5.1 Value Chain Analysis

5.2 Porters Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger And Acquisition Landscape

5.7 Upcoming Trends

5.7.1 Market Trends

5.7.2 Technological Trends

5.7.3 Insurance & Regulations

5.7.4 Others

Chapter 6. Middle-East And Africa Hypertension Drugs Market By Type

Chapter 7. Middle-East And Africa Hypertension Drugs Market By Region

7.1 Introduction

7.2 Middle East

7.2.1 UAE

7.2.2 Saudi Arabia

7.2.3 Egypt

7.2.4 Others

7.3 Africa

...CONTINUED

Feel free to get in touch for discounts and customized details: https://www.marketresearchfuture.com/check-discount/2636 .

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Middle-East and Africa Hypertension Drugs Market 2018 | Top 10 Major Participants: Abbott, Johnson & Johnson Services, Inc., Novartis, GlaxoSmithKline plc., AstraZeneca, Bayer AG here

News-ID: 993436 • Views:

More Releases from Market Research Future - MRFR

Explosives Market Set to Reach USD 40.2 Billion, with a Healthy 2.13% CAGR Till Forecasts 2035
Explosives Market Set to Reach USD 40.2 Billion, with a Healthy 2.13% CAGR Till …
The explosives market encompasses the production, distribution, and application of energetic materials used across a wide range of sectors - from mining, quarrying, and construction to defense, demolition, and special industrial applications. Explosives are engineered formulations designed to release energy rapidly and are typically classified by sensitivity, velocity of detonation, and intended use. While military applications attract attention for their strategic importance, commercial explosives for mining and infrastructure development constitute
India Water Treatment Market Expected to Achieve a Strong 10.60% CAGR, to Reach USD 6.30 Billion by 2034
India Water Treatment Market Expected to Achieve a Strong 10.60% CAGR, to Reach …
Water treatment in India has become a crucial sector due to rapid urbanization, industrial growth, rising population, and increasing environmental challenges. With growing concerns about water scarcity, pollution, and the need for safe drinking water, India's water treatment industry plays a vital role in supporting public health, sustainable agriculture, and industrial operations. The country faces significant challenges, including contamination of surface and groundwater, high demand from agricultural and industrial sectors, and
USA Pulp and Paper Market Forecasted to Reach USD 69.33 Billion By 2034, at an Impressive 1.00% CAGR
USA Pulp and Paper Market Forecasted to Reach USD 69.33 Billion By 2034, at an I …
The United States pulp and paper industry is one of the oldest and most established manufacturing sectors in the country. It has played a crucial role in supporting industries ranging from publishing and education to packaging, hygiene, and industrial applications. Despite digitalization reducing demand for traditional printing and writing paper, the market has successfully adapted by shifting toward sustainable packaging solutions, tissue products, and specialty paper. Pulp, produced mainly from wood
US Graphene Market Projected to Reach USD 850 Million, with a Robust 29.37% CAGR Till 2035
US Graphene Market Projected to Reach USD 850 Million, with a Robust 29.37% CAGR …
Graphene, a one-atom-thick sheet of carbon atoms arranged in a two-dimensional honeycomb lattice, is widely recognized as one of the most promising advanced materials of the 21st century. Known for its exceptional electrical conductivity, mechanical strength, thermal conductivity, and transparency, graphene has the potential to revolutionize multiple industries including electronics, energy storage, composites, healthcare, and coatings. In the United States, graphene research and commercialization have been advancing rapidly, supported by strong

All 5 Releases


More Releases for Hypertension

Hypertension Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hypertension Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Hypertension pipeline landscape. It covers the Hypertension pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hypertension pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Hypertension Pipeline Report • DelveInsight's Hypertension
Hypertension Drugs Market - Breaking the Pressure: Hypertension Drugs Redefining …
Newark, New Castle, USA: The "Hypertension Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Hypertension Drugs Market: https://www.growthplusreports.com/report/hypertension-drugs-market/8760 This latest report researches the industry structure, sales, revenue,
Hypertension Management Devices Market: Rise in Prevalence of Resistant Hyperten …
Market Analysis and Insights of Hypertension Management Devices Market Hypertension Management Devices Market to account USD 9.50 billion and growing at a CAGR of 7.27% by 2032. Although there are still numerous variations available, the major market players are currently developing and testing clinical versions of hypertension treatment devices. Due to the lack of available effective medications, these medical devices are being created with the primary goal of managing cardiovascular illnesses
Anti-hypertension - Drug Pipeline Landscape, 2022
Hypertension also known as high blood pressure is a condition where the force of blood pushing against the arterial walls of heart is consistently higher than the normal. Hypertension can be identified as primary/essential (without a known cause such as age, genetics, sedentary lifestyle, alcohol consumption, high sodium intake etc.) and secondary (due to an underlying condition as its cause such as congenital heart defects, kidney diseases, endocrinal issues, side
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
Renal Hypertension: Diagnosis & Treatment
“Hypertension & Cardiovascular disease after Kidney Transplantation” is one of the workshops to be conducted by Dr. Hossein Tabriziani of Loma Linda University, USA under the session ‘Renal Hypertension’ at the meeting 2nd International Conference on Hypertension & Healthcare which is going to be held at Amsterdam, Netherlands during September 11-13, 2017. High blood pressure is a leading cause of kidney disease and kidney failure ESRD (end stage renal disease). Hypertension